Quantum Cyber N.V. Selling, General and Administrative Expense
Quantum Cyber N.V. (QUCY) reported Selling, General and Administrative Expense of $1.59 million for the 3-month period ending 2023-03-31, per its 6-K filed 2023-05-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-05-16
- Quantum Cyber N.V. selling, general and administrative expense for the quarter ending 2023-03-31 was $1.59M, a 62.07% decline year-over-year.
- Quantum Cyber N.V. selling, general and administrative expense for the quarter ending 2022-03-31 was $4.19M.
| Period end | Selling, General and Administrative Expense 3 month |
|---|---|
| 2023-03-31 | $1.59M 6-K · filed 2023-05-16 |
| 2022-03-31 | $4.19M 6-K · filed 2023-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |